116 related articles for article (PubMed ID: 22771598)
1. Consistency of standard laboratory strain Mycobacterium tuberculosis H 37 Rv with ethionamide susceptibility testing.
Lakshmi R; Kumar V; Rahman F; Ramachandran R
Indian J Med Res; 2012 May; 135(5):672-4. PubMed ID: 22771598
[TBL] [Abstract][Full Text] [Related]
2. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Şimşek H; Tarhan G; Cesur S
Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
[TBL] [Abstract][Full Text] [Related]
4. Resistance of multidrug-resistant strains of Mycobacterium tuberculosis from the Archangel oblast, Russia, to second-line anti-tuberculosis drugs.
Toungoussova OS; Mariandyshev AO; Bjune G; Caugant DA; Sandven P
Eur J Clin Microbiol Infect Dis; 2005 Mar; 24(3):202-6. PubMed ID: 15742171
[TBL] [Abstract][Full Text] [Related]
5. Second-line drug susceptibilities of Thai multidrug-resistant Mycobacterium tuberculosis isolates.
Prammananan T; Arjratanakool W; Chaiprasert A; Tingtoy N; Leechawengwong M; Asawapokee N; Leelarasamee A; Dhiraputra C
Int J Tuberc Lung Dis; 2005 Feb; 9(2):216-9. PubMed ID: 15732744
[TBL] [Abstract][Full Text] [Related]
6. [The rates of resistance to second-line drugs in multidrug resistant Mycobacterium tuberculosis strains].
Kayali R; Cöplü N; Ceyhan I; Ocak F; Citil BE; Esen B
Mikrobiyol Bul; 2006; 40(1-2):1-7. PubMed ID: 16775950
[TBL] [Abstract][Full Text] [Related]
7. Modification of proportion sensitivity testing method for ethionamide.
Lakshmi R; Ramachandran R; Devika K; Radhika G; Syam Sundar A; Rahman F; Selvakumar N; Kumar V
World J Microbiol Biotechnol; 2013 Jun; 29(6):1117-9. PubMed ID: 23315266
[TBL] [Abstract][Full Text] [Related]
8. Pre-XDR & XDR in MDR and Ofloxacin and Kanamycin resistance in non-MDR Mycobacterium tuberculosis isolates.
Jain A; Dixit P; Prasad R
Tuberculosis (Edinb); 2012 Sep; 92(5):404-6. PubMed ID: 22789499
[TBL] [Abstract][Full Text] [Related]
9. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
Kam KM; Yip CW
Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
[TBL] [Abstract][Full Text] [Related]
10. Use of MGIT 960 for rapid quantitative measurement of the susceptibility of Mycobacterium tuberculosis complex to ciprofloxacin and ethionamide.
Huang TS; Lee SS; Tu HZ; Huang WK; Chen YS; Huang CK; Wann SR; Lin HH; Liu YC
J Antimicrob Chemother; 2004 Apr; 53(4):600-3. PubMed ID: 14973155
[TBL] [Abstract][Full Text] [Related]
11. High-level resistance to isoniazid and ethionamide in multidrug-resistant Mycobacterium tuberculosis of the Lisboa family is associated with inhA double mutations.
Machado D; Perdigão J; Ramos J; Couto I; Portugal I; Ritter C; Boettger EC; Viveiros M
J Antimicrob Chemother; 2013 Aug; 68(8):1728-32. PubMed ID: 23539241
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization and second-line antituberculosis drug resistance patterns of multidrug-resistant Mycobacterium tuberculosis isolates from the northern region of South Africa.
Said HM; Kock MM; Ismail NA; Mphahlele M; Baba K; Omar SV; Osman AG; Hoosen AA; Ehlers MM
J Clin Microbiol; 2012 Sep; 50(9):2857-62. PubMed ID: 22649019
[TBL] [Abstract][Full Text] [Related]
13. [Development of resistance of Mycobacterium tuberculosis to cycloserine, ethionamide, kanamycin, florimycin in experiments in vitro].
Mkrtchian SV
Antibiotiki; 1968 Oct; 13(10):907-10. PubMed ID: 4303355
[No Abstract] [Full Text] [Related]
14. Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
Lin SY; Desmond E; Bonato D; Gross W; Siddiqi S
J Clin Microbiol; 2009 Nov; 47(11):3630-4. PubMed ID: 19741086
[TBL] [Abstract][Full Text] [Related]
15. Molecular detection of drug resistance to ofloxacin and kanamycin in Mycobacterium tuberculosis by using multiplex allele-specific PCR.
Kumari R; Banerjee T; Anupurba S
J Infect Public Health; 2018; 11(1):54-58. PubMed ID: 28404233
[TBL] [Abstract][Full Text] [Related]
16. Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Bakuła Z; Napiórkowska A; Kamiński M; Augustynowicz-Kopeć E; Zwolska Z; Bielecki J; Jagielski T
J Microbiol Immunol Infect; 2016 Jun; 49(3):439-44. PubMed ID: 26117528
[TBL] [Abstract][Full Text] [Related]
17. Testing susceptibility of multidrug-resistant Mycobacterium tuberculosis to second-line drugs by use of blood agar.
Satana D; Coban AY; Uzun M
J Clin Microbiol; 2010 Nov; 48(11):4291-3. PubMed ID: 20826642
[TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
Lai CC; Tan CK; Huang YT; Liao CH; Hsueh PR
J Antimicrob Chemother; 2011 Oct; 66(10):2437-8. PubMed ID: 21798881
[No Abstract] [Full Text] [Related]
19. Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates.
Rueda J; Realpe T; Mejia GI; Zapata E; Rozo JC; Ferro BE; Robledo J
Antimicrob Agents Chemother; 2015 Dec; 59(12):7805-10. PubMed ID: 26369965
[TBL] [Abstract][Full Text] [Related]
20. Resistance patterns among multidrug-resistant tuberculosis patients in greater metropolitan Mumbai: trends over time.
Dalal A; Pawaskar A; Das M; Desai R; Prabhudesai P; Chhajed P; Rajan S; Reddy D; Babu S; Jayalakshmi TK; Saranchuk P; Rodrigues C; Isaakidis P
PLoS One; 2015; 10(1):e0116798. PubMed ID: 25606853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
